FDA Approves a New Drug for Postpartum Depression

      For the first time, the FDA has approved a new drug exclusively for the treatment of postpartum depression.  The new drug,  Zulresso (brexanolone) is only available in injection form, given over sixty hours and requires an inpatient stay.  At 34,000 dollars per treatment, many experts worry about the accessibility of the patients  most in […]

The post FDA Approves a New Drug for Postpartum Depression appeared first on The Recover.

source https://www.therecover.com/fda-approves-a-new-drug-for-postpartum-depression/